Bristol-Myers Squibb
BMY
2,218 hedge funds and large institutions have $113B invested in Bristol-Myers Squibb in 2019 Q4 according to their latest regulatory filings, with 492 funds opening new positions, 1,219 increasing their positions, 390 reducing their positions, and 57 closing their positions.
763% more first-time investments, than exits
New positions opened: 492 | Existing positions closed: 57
213% more repeat investments, than reductions
Existing positions increased: 1,219 | Existing positions reduced: 390
121% more funds holding in top 10
Funds holding in top 10: 48 → 106 (+58)
63% more capital invested
Capital invested by funds: $69.6B → $113B (+$43.5B)
22% more funds holding
Funds holding: 1,814 → 2,218 (+404)
8.53% less ownership
Funds ownership: 83.94% → 75.42% (-8.5%)
62% less call options, than puts
Call options by funds: $1.84B | Put options by funds: $4.81B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.46B |
| 2 |
BlackRock
New York
|
+$2.71B |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.79B |
| 4 |
Renaissance Technologies
New York
|
+$1.57B |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.27B |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.5B |
| 2 |
BG
Baupost Group
Boston,
Massachusetts
|
-$344M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$334M |
| 4 |
PP
Prudential plc
London, England,
United Kingdom
|
-$224M |
| 5 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
-$167M |
BMY Hedge Fund Activity: Q4 2019 in Review
2,218 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q4 2019, worth a combined $113B — up 63% from $69.6B a quarter earlier.
Buyers outnumbered sellers: 492 funds opened new BMY positions and 57 closed out — a net gain of 435 holders — while 1,219 added to existing stakes and 390 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.46B. The largest seller was Wellington Management Group, cutting an estimated $1.5B.
- 2,218 institutional investors held Bristol-Myers Squibb (BMY) as of Q4 2019, up from 1,814 in Q3 2019.
- Funds reported $113B of Bristol-Myers Squibb stock for Q4 2019, up 63% quarter-over-quarter.
- 492 funds opened new Bristol-Myers Squibb positions in Q4 2019 and 57 closed out, a net change of +435 holders.
- The largest Bristol-Myers Squibb buyer in Q4 2019 was Vanguard Group, an estimated $3.46B added.
- The largest Bristol-Myers Squibb seller in Q4 2019 was Wellington Management Group, an estimated $1.5B sold.
Based on aggregated 13F filings for Q4 2019.